01
Thursday
Main stage · 08:00–21:00
- Clinical trials and regulatory pathways
- AI in healthspan trials
- Patient access and clinical practice
ARDD
2026
13th Aging Research and Drug Discovery Meeting
October 1–3, 2026
David Rubenstein Treehouse at Harvard University
20 Western Avenue · Allston, Massachusetts
20 Western Avenue · Allston, Massachusetts
Harvard University · Allston
ARDD 2026
A meeting built across disciplines.
Three days connecting aging biology, clinical translation, drug discovery, artificial intelligence and investment — in one shared programme.
137+participants and speakers
3days at the Treehouse
4thematic forums
2programme rooms
2
One shared space.
Designed for collisions between disciplines, companies and ideas.
3
At Harvard University.
A purpose-built meeting place in Allston, connected to the research community around it.
4
Venue guide
Everything under one roof.
Use the central stair to move between the main stage and parallel forums. Registration and event staff can help with accessibility routes.
agingpharma.org/location
3/F
Canopy HallMain stage · October 1–3
2/F
Cedar GroveAI and thematic forums
1/F
ArrivalRegistration · cloakroom · event support
David Rubenstein Treehouse
20 Western Avenue · Allston, Massachusetts
20 Western Avenue · Allston, Massachusetts
5
Programme overview
Three days at a glance
02
Friday
Main stage · 08:00–21:00
- Drug discovery and pharma R&D
- Partnering, licensing and investment
- Special speaker event
6
03
Saturday
Main stage · 08:00–19:00
- Search and evaluation
- Therapeutic assets and licensing
- Parallel longevity forums
Four thematic forums
01
Longevity Medicine ForumIndependent live schedule
02
AI in Drug Discovery ForumCedar Grove · 09:00–18:40
03
Pet and Animal Longevity ForumCedar Grove · 09:00–12:20
03
Virtual Cell in Time ForumIndependent live schedule
7
08:00–21:00
October · Thursday
01
Main stage
8
01·Main stage
08:00–09:30
08:00–09:00
Breakfast and registration
09:00–09:10
Opening
George Daley
Dean · Harvard Medical School
09:10–09:20
Chair Opening Introduction
Evelyne Bischof
Professor · Sheba Medical Center
Alex Zhavoronkov
CEO · Insilico Medicine
Vadim Gladyshev
Professor · Harvard Medical School
Morten Scheibye-Knudsen
Professor · University of Copenhagen
Jesse Poganik
Instructor · Harvard Medical School
09:20–09:30
Jamie Justice
Executive Vice President of the Health Domain · XPRIZE Healthspan
9
01·Main stage
09:30–11:20
09:30–09:50
SG
Policy & Regulatory Address
Special guest keynote
Portrait unavailable · details to be confirmed
09:50–10:00
Clinical trials for aging, how ARPA-H PROSPR is building the train tracks to support a future industry
Andrew Brack
Program Manager, Proactive Health · ARPA-H
10:00–10:50
Matching Clinical Trials of Therapeutics & Regulatory Mandates
Andrew Brack
moderator
Program Manager, Proactive Health · ARPA-H
Jeffrey Siegel
panelist
Director, Drug Evaluation Sciences · FDA
Justin Penzenstadler
panelist
Associate Director (Acting) · OCHEN/OND/CDER/FDA
Lowell M. Zeta
panelist
Acting Chief of Staff, Office of the Commissioner · FDA
10:50–11:20
Morning networking break
10
01·Main stage
11:20–13:00
11:20–12:00
Clinical Trials in Diseases of Aging: From Evidence to New Therapeutics and Regulatory Pathways
Sebastian Thuault
moderator
Editor · Nature Medicine
Steven Quay
panelist
CEO · Atossa Therapeutics
Jill Lee
panelist
Director, Regulatory Policy and Intelligence · Novo Nordisk
Calum MacRae
panelist
Professor · Mass General Brigham
Christoph Westphal
panelist
General Partner · Longwood Fund
Steve Horvath
panelist
Professor · UCLA
12:00–13:00
Lunch break
11
01·Main stage
13:00–15:00
13:00–14:00
AI & Clinical Trials in Healthspan
Session programme
Andrew Shin
moderator
Chief Strategy Officer · Mass General Brigham
13:00–13:20
Elena Bonfiglioli
Global Business Leader, Healthcare and Life Sciences · Microsoft
13:20–13:40
Wei-Wu He
CEO · Human Longevity, Inc.
13:40–14:00
Evelyne Bischof
Professor · Sheba Medical Center
14:00–15:00
Healthspan in Leading Industries
Session programme
JJ
Josh JoynerTBC
moderator
Editor · Forbes Health
14:00–14:20
Stephanie Manson-Brown
Head of Clinical Development and Scientific Innovation · AbbVie
14:20–14:40
Laure Crabbe-Vert
Senior Life Science Innovation Manager · LVMH Research
14:40–15:00
Philipp Gut
Adult Health and Healthy Longevity Research Lead · Nestlé
12
01·Main stage
15:00–16:30
15:00–15:30
Afternoon networking break and poster session
15:30–16:30
Aging Research and Pharma R&D Productivity
Session programme
Lisa Melton
moderator
Senior News Editor · Nature Biotechnology
15:30–15:50
Michael Li
Assistant Professor · Harvard Business School
15:50–16:10
Alexander Schuchmacher
Professor · Technische Hochschule Ingolstadt
16:10–16:30
Michael Ringel
COO · Life Biosciences
13
01·Main stage
16:30–21:00
16:30–17:30
Clinical Healthspan Trials and Practice
Session programme
Barbara Cheifet
moderator
Chief Editor · Nature Biotechnology
16:30–16:50
Vishwa Deep Dixit
Professor · Yale School of Medicine
16:50–17:10
James Kirkland
Professor · Cedars-Sinai Medical Center
17:10–17:30
Nicole Sirotin
CEO · Institute for Healthier Living Abu Dhabi
17:30–18:10
From Healthspan Trials to Clinical Practice: Building the Path to Patient Access
Michael Basson
moderator
Editor · Nature Medicine
David Dodick
panelist
CMO/Professor · Atria Health Institute/Mayo Clinic
Sara Bonnes
panelist
Professor · Mayo Clinic College of Medicine
Erwin Tan
panelist
Senior Director · AARP
18:10–18:20
Closing remarks
18:30–21:00
Open Bar
14
Independent forum programme
Longevity Medicine Forum
This forum has its own evolving schedule. The live programme is the source of truth for sessions, speakers and room updates.
October 1 · Thursday
Venue and agenda in the live programme
Venue and agenda in the live programme
Live schedule
agingpharma.org/program2026
15
08:00–21:00
October · Friday
02
Main stage
16
02·Main stage
08:00–09:35
08:00–09:00
Breakfast and registration
09:00–09:15
Chair Opening Introduction
Alex Zhavoronkov
CEO · Insilico Medicine
Vadim Gladyshev
Professor · Harvard Medical School
Morten Scheibye-Knudsen
Professor · University of Copenhagen
Daniela Bakula
Professor · University of Copenhagen
Jesse Poganik
Instructor · Harvard Medical School
09:15–09:35
Reimagining Drug Discovery Through the Lens of Aging Biology
Fiona Marshall
President, Biomedical Research · Novartis
17
02·Main stage
09:35–10:40
09:35–10:20
Pharma Chief Executive Panel
Alice Park
moderator
Senior Health Correspondent · TIME
Christophe Weber
panelist
Ex-CEO · Takeda
Elcin Barker Ergun
panelist
CEO · Menarini
Fiona Marshall
panelist
President, Biomedical Research · Novartis
Ariel Feldstein
panelist
CSO, Internal Medicine · Pfizer
10:20–10:40
Alex Zhavoronkov
CEO · Insilico Medicine
18
02·Main stage
10:40–12:10
10:40–11:00
Kevin Duffin
VP, Aging Research · Eli Lilly
11:00–11:30
Morning networking break and group photo
11:30–12:10
New Technology Partnering & Licensing
Alex Philippidis
moderator
Senior Business Editor · Genetic Engineering and Biotechnology News
Morten Sogaard
panelist
SVP, Head of Astellas Innovation Lab · Astellas
Christopher Austin
panelist
SVP, R&D Technologies · GSK
Alex Cogdill
panelist
Head of Strategic Initiatives, Global Business Development · Daiichi Sankyo
Vishnu Sresht
panelist
Director, Computational Chemistry and Machine Learning · Genentech
Carl Gordon
panelist
Managing Partner · OrbiMed
19
02·Main stage
12:10–14:10
12:10–12:30
George Church
Professor · Harvard Medical School
12:30–13:30
Lunch break
13:30–13:50
BioAge–Novartis joint presentation
Sophie Lemire-Brachat
Executive Director, Translational and Data Science · Novartis
Naisha Shah
Senior Vice President of Data Science · BioAge
13:50–14:10
Maxwell Biosciences
Company presentation
20
02·Main stage
14:10–15:30
14:10–14:30
Biocytogen
Company presentation
14:30–14:50
Circulating proteins reveal and regulate cell and organ function
Tony Wyss-Coray
Professor · Stanford University
14:50–15:30
Diseases as a Pathway to Longevity Therapeutics: Which age-related disease resembles aging most closely?
Barbara Cheifet
moderator
Chief Editor · Nature Biotechnology
Ruth Gimeno
panelist
VP, Diabetes, Obesity and Cardiometabolic R&D · Eli Lilly
Ariel Feldstein
panelist
CSO, Internal Medicine · Pfizer
Carine Boustany
panelist
SVP, Immunology and Respiratory Diseases · Boehringer Ingelheim
21
02·Main stage
15:30–16:40
15:30–16:00
Afternoon networking break and poster session
16:00–16:40
Early Stage Investor Panel
Sergey Jakimov
panelist
Founding and Managing Partner · LongeVC
Arie Belldegrun
panelist
Co-Founder · Bellco Capital
Yan Lei
panelist
CEO · Synaro Capital
Gérôme Guiot
panelist
Strategic Projects Director · LVMH
Chuen Yan Leung
panelist
Partner, Healthcare Investment · Value Partners Group
Amol Pawar
moderator
Executive Director · UBS
22
02·Main stage
16:40–17:40
16:40–17:20
Full-Stack and Growth Stage Investor Panel
Patrick Temple-West
moderator
Journalist · Financial Times
Jim Flynn
panelist
Managing Partner · Deerfield
Alfredo Viegas
panelist
Managing Director · Oaktree Capital Management
Murali Venkatesan
panelist
Global Head of Danaher Ventures · Danaher
Kan Chen
panelist
Partner · Qiming Venture Partners
17:20–17:40
Kirsten Seale
Scientist · TruDiagnostic
23
02·Main stage
17:40–21:00
17:40–18:00
Marco Quarta
Co-Founder, CSO · Rubedo Life Sciences
18:00–18:20
Using buccal methylomic data to generate novel insights into epigenetic aging
Adiv Johnson
CSO · Tally Health
18:20–18:40
Gordan Lauc
Professor · University of Zagreb
18:40–21:00
Open Bar
19:00–21:00
Special speaker event
24
09:00–18:40
October · Friday
02
AI in Drug Discovery Forum
25
02·AI in Drug Discovery Forum
09:00–10:10
09:00–09:10
Opening remarks and welcome
Session I: AI & Computational Design in Drug Discovery
09:10–09:30
Yves Fomekong Nanfack
Head of ML · Takeda
09:30–09:50
Alex Zhavoronkov
CEO · Insilico Medicine
09:50–10:10
Peter Clark
VP, Computational Drug Design · Novo Nordisk
26
02·AI in Drug Discovery Forum
10:10–11:45
10:10–10:30
Reproducibility-Aware AI for Drug Discovery: Purrsistence as a Service
Alexandru-Ioan Voda
CEO · Cat Health Company
10:30–10:45
Coffee break
Session II: Large Scale Datasets to Feed Future AIs
10:45–11:05
Proteomic Clocks for Target Nomination
Jonathan Gootenberg
Assistant Professor · Harvard Medical School
11:05–11:25
Joe Betts-LaCroix
CEO · Retro
11:25–11:45
Biomedical Mega Projects for Data Collection in Longevity
Max Unfried
Scientific Director · The Thalion Initiative
27
02·AI in Drug Discovery Forum
11:45–14:00
11:45–12:30
What Does AI in Longevity Biotech Really Need? And How Can Private Capital Markets and Philanthropy Fill This Gap?
RR
Raiany Romanni-Klein
moderator
PhD · Harvard
Nisa Leung
panelist
Managing Partner · Aulis Capital
PK
Peter Kolchinsky
panelist
Managing Partner · RA Capital Management
TC
Thomas Clozel
panelist
CEO · Owkin
Martin Borch Jensen
panelist
Co-Founder and CSO · Gordian Biotechnology
TW
Todd White
panelist
Managing Director · The Thalion Initiative
12:30–13:30
Lunch break
13:30–13:40
Opening remarks and welcome
Session III: Targeting Neurodegeneration with AI
13:40–14:00
AI4Cure-AD Platform for Alzheimer's Disease Drug Development
Feixiong Cheng
Director, Genome Center · Cleveland Clinic
28
02·AI in Drug Discovery Forum
14:00–15:35
14:00–14:20
DeepDrugX for Alzheimer's Disease Drug Discovery
Jacqueline Lam
Scholar · University of Cambridge
14:20–14:40
LLMs to Flip the Script on Neuroimmune Aging Targets
Gerald Lushington
Expert Team Lead · SpaceX · Qnapsyn Biosciences, Inc.
14:40–15:20
Beyond Decline: Next-Generation Targets in Neuro Aging
SM
Sarah Mitchell
moderator
Editor in Chief · npj Aging
Derek Huffman
panelist
Professor, Molecular Pharmacology and Medicine · Albert Einstein College of Medicine
Sergey Jakimov
panelist
Founding and Managing Partner · LongeVC
MM
Mahdi Moqri
panelist
Harvard
15:20–15:35
Coffee break
29
02·AI in Drug Discovery Forum
15:35–17:20
Session IV: AI for Systems Immunology & Immune Aging
15:35–15:55
David Furman
Professor · Buck Institute
15:55–16:15
BioInton
16:15–16:35
AI Antibody Design
Debora Marks
Professor · Harvard
16:35–17:20
Panel Discussion
Derya Unutmaz
moderator
Professor · Jackson Lab
Andrea Cipriano
panelist
Director of Immunology · Eli Lilly; Adjunct Professor · Stanford
TZ
Tina Ziainia
panelist
Human Longevity
30
02·AI in Drug Discovery Forum
17:20–18:40
17:20–17:35
Coffee break
Session V: Mix
17:35–17:55
Derya Unutmaz
Professor · Jackson Lab
17:55–18:15
BioLens: An LLM-Enabled Literature Database for Systematic Analysis of Mouse Lifespan Research
Kia Winslow
Director · BioAge
18:15–18:35
Salah Mahmoudi
CEO · ReneuBio
18:35–18:40
Wrap-up
31
08:00–19:00
October · Saturday
03
Main stage
32
03·Main stage
08:00–09:55
08:00–09:00
Breakfast and registration
09:00–09:15
Chair Opening Introduction
Alex Zhavoronkov
CEO · Insilico Medicine
Vadim Gladyshev
Professor · Harvard Medical School
Morten Scheibye-Knudsen
Professor · University of Copenhagen
Daniela Bakula
Professor · University of Copenhagen
Jesse Poganik
Instructor · Harvard Medical School
09:15–09:35
Jim O'NeillTentative
Speaker details to be confirmed
09:35–09:55
Vadim Gladyshev
Professor · Harvard Medical School
33
03·Main stage
09:55–12:30
09:55–10:15
Mark Cobbold
SVP, IO Discovery and Cell Therapy Oncology · AstraZeneca
10:15–11:00
Search & Evaluation Strategies for Longevity Therapeutics
Lisa Melton
moderator
Senior News Editor · Nature Biotechnology
Thomas Marron
panelist
AVP, Emerging Innovation and Strategic Growth · Eli Lilly
Kaivan Khavandi
panelist
SVP, Respiratory, Immunology and Inflammation R&D · GSK
Tala Fakhouri
panelist
Chief AI and Regulatory Strategy Officer · Parexel
11:00–11:30
Morning networking break and group photo
11:30–12:10
Metabolic health and longevity symposium by Nestlé Research
Participants will be announced in the live programme.
12:10–12:30
Holistic approach to aging population
Alejandro Aguayo-Orozco
Senior Scientific Director, Diabetes Insights · Novo Nordisk
34
03·Main stage
12:30–14:50
12:30–13:30
Lunch break
13:30–14:10
Aging research in pharma
Sebastian ThuaultTBC
moderator
Editor · Nature Aging
Sophie Lemire-Brachat
panelist
Executive Director, Translational and Data Science · Novartis
Maria Dermit
panelist
Scientist · Novo Nordisk
Björn Tackenberg
panelist
Head of Integrative Neuroscience · Roche
William Mair
panelist
Professor of Molecular Metabolism · Harvard University
14:10–14:50
Therapeutic Assets & Licensing (Late Stage)
Cailin McGurk
moderator
Managing Director · Morgan Stanley
Monika Vnuk
panelist
SVP, Global Head of Partnering and Business Development · Sanofi
Phil McGurk
panelist
SVP, Head of Global Business Development · Takeda
35
03·Main stage
14:50–16:40
14:50–15:10
Martin Borch Jensen
Co-Founder and CSO · Gordian Biotechnology
15:10–15:30
Cambrian Bio
Company presentation
15:30–16:00
Afternoon networking break and poster session
16:00–16:40
Therapeutic Assets & Licensing (Early Stage)
Brianna Stubbs
moderator
Director of Translational Science · Buck Institute
Jonathan Levi
panelist
Senior Director, R&D Strategy · AstraZeneca
Xingli Wang
panelist
Global Partner · Fosun Pharma
Claris Munksgaard
panelist
Director, Business Development and Licensing · EMD Serono/Merck
Nikolaj Kulahin RoedTBC
panelist
Global Project Leader · Novo Nordisk
36
03·Main stage
16:40–19:00
16:40–17:00
Johan Luthman
EVP, R&D · Lundbeck
17:00–17:20
Tolerance Bio
Company presentation
17:20–17:40
Matthew O’Connor
CEO · Cyclarity Therapeutics
17:40–18:00
Brian Bodemann
CEO · ARTAN Bio
18:00–18:20
David Sinclair
Professor · Harvard Medical School
18:20–18:40
Morten Scheibye-Knudsen
Professor · University of Copenhagen
18:40–19:00
Closing remarks
37
09:00–12:20
October · Saturday
03
Pet and Animal Longevity Forum
38
03·Pet and Animal Longevity Forum
09:00–10:30
09:00–09:10
Opening remarks and welcome
Max Unfried
Scientific Director · The Thalion Initiative
Session I: Canine Aging
09:10–09:30
The Companion Dog as a Translational Model of Aging
Dan Promislow
Senior Scientist and Scientific Advisor · HNRCA, Tufts University
09:30–09:50
Nutrition to Slow Biological Aging in Dogs
Philipp Gut
Adult Health and Healthy Longevity Research Lead · Nestlé
09:50–10:10
Vicky Yang
Associate Professor · Tufts University
10:10–10:30
Surrogate Endpoints for Veterinary Geroprotector Trials: The Case for Methylation Clocks
Steve Horvath
Professor · UCLA
39
03·Pet and Animal Longevity Forum
10:30–12:20
10:30–10:45
Coffee break
Session II: Commercializing Pet Longevity
10:45–11:05
Fireside Chat
Anna Skaya
General Partner · AniVC
Garri Zmudze
Partner · AniVC
11:05–11:25
Zoetis
11:25–11:45
GB
Graeme Bainbridge
Senior Principal Scientist · Dechra
11:45–12:20
Panel Discussion
Dan Promislow
panelist
HNRCA, Tufts University
Philipp Gut
panelist
Adult Health and Healthy Longevity Research Lead · Nestlé
40
Independent forum programme
Virtual Cell in Time: Virtual Aging Cell Forum
This forum has its own evolving schedule. The live programme is the source of truth for sessions, speakers and room updates.
October 3 · Saturday
Venue and agenda in the live programme
Venue and agenda in the live programme
Live schedule
agingpharma.org/program2026
41
Participant index
Speakers
A—C
Omar Abudayyeh
Professor, Harvard Medical School
Alejandro Aguayo-Orozco
Senior Scientific Director, Novo Nordisk
Kawthar Al Ameri
Division Director of NCDs Surveillance and Screening, Abu Dhabi Public Health Center
Christopher Austin
SVP, GSK
Graeme Bainbridge
Senior Principal Scientist · Dechra
Daniela Bakula
Professor, University of Copenhagen
Michael Basson
Senior Editor, Nature Medicine
Arie Belldegrun
Co-Founder · Bellco Capital
Joe Betts-LaCroix
CEO · Retro
Evelyne Bischof
Scientist, Sheba Longevity Center
Brian Bodemann
ARTAN Bio
Elena Bonfiglioli
Global Business Leader, Healthcare and Life Sciences · Microsoft
Sara Bonnes
Professor, Mayo Clinic College of Medicine
Carine Boustany
SVP, Immunology and Respiratory Diseases · Boehringer Ingelheim
Andrew Brack
Program Manager, Proactive Health · ARPA-H
Barbara Cheifet
Chief Editor, Nature Biotechnology
42
Speaker index · continued
C—F
Kan Chen
Investor, Qiming Venture Partners
Feixiong Cheng
Director, Genome Center · Cleveland Clinic
George Church
Professor, Harvard Medical School
Andrea Cipriano
Director of Immunology · Eli Lilly; Adjunct Professor · Stanford
Peter Clark
VP, Computational Drug Design · Novo Nordisk
Thomas Clozel
CEO · Owkin
Mark Cobbold
SVP, AstraZeneca
Alex Cogdill
Head of Strategic Initiatives, Daiichi Sankyo
Laure Crabbe-Vert
Senior Life Science Innovation Manager, LVMH Research
George Daley
Dean of the Faculty of Medicine · Harvard Medical School
Maria Dermit
Scientist, Novo Nordisk
Vishwa Deep Dixit
Professor, Yale School of Medicine
David Dodick
CMO, The Atria Health Institute
Kevin Duffin
VP, Eli Lilly
Elcin Barker Ergun
CEO, Menarini Group
Tala Fakhouri
Chief AI and Regulatory Strategy Officer · Parexel
43
Speaker index · continued
F—J
Ariel Feldstein
CSO, Pfizer
Jim Flynn
Managing Partner, Deerfield
David Furman
Professor and Director, Buck Institute for Research on Aging
Ruth Gimeno
VP, Diabetes, Obesity and Cardiometabolic R&D · Eli Lilly
Vadim Gladyshev
Professor, Harvard Medical School
Jonathan Gootenberg
Assistant Professor · Harvard Medical School
Carl Gordon
Managing Partner, OrbiMed
Gérôme Guiot
Director, LVMH
Philipp Gut
Adult Health and Healthy Longevity Research Lead · Nestlé
Wei-Wu He
CEO, Human Longevity Inc.
Steve Horvath
Professor, University of California, Los Angeles
Derek Huffman
Professor, Molecular Pharmacology and Medicine · Albert Einstein College of Medicine
Sergey Jakimov
Founding and Managing Partner · LongeVC
Martin Borch Jensen
Co-Founder and CSO · Gordian Biotechnology
Adiv Johnson
CSO, Tally Health
44
Speaker index · continued
J—L
Josh Joyner
Editor · Forbes Health
Jamie Justice
Executive Vice President, Health Domain and Executive Director, XPRIZE Healthspan · XPRIZE Foundation
Avak Kahvejian
General Partner · Flagship Pioneering
Kaivan Khavandi
SVP, Respiratory, Immunology and Inflammation R&D · GSK
James Kirkland
Professor, Robert and Arlene Kogod Center on Aging
Peter Kolchinsky
Managing Partner · RA Capital Management
Jacqueline Lam
Scholar, University of Cambridge
Gordan Lauc
Professor, University of Zagreb
Jill Lee
Director, Novo Nordisk
Yan Lei
CEO, Synaro Capital
Sophie Lemire-Brachat
Executive Director, Translational and Data Science · Novartis
Francisco Leon
Founder and CEO · Tolerance Bio
Chuen Yan Leung
Investor, Value Partners Group
Nisa Leung
Managing Partner · Aulis Capital
Jonathan Levi
Senior Director, AstraZeneca
45
Speaker index · continued
L—M
Michael Li
Assistant Professor · Harvard Business School
Michael Lingzhi Li
Assistant Professor of Business Administration · Harvard Business School
Gerald Lushington
Expert Team Lead · SpaceX/Qnapsyn Biosciences, Inc.
Johan Luthman
EVP, Lundbeck
Calum MacRae
Professor, Mass General Brigham Heart and Vascular Institute
Salah Mahmoudi
Co-Founder and CEO · ReneuBio
William Mair
Professor · Harvard T.H. Chan School of Public Health
Stephanie Manson-Brown
Head of Clinical Development and Scientific Innovation · AbbVie
Debora Marks
Professor, Harvard Medical School
Thomas Marron
AVP, Eli Lilly
Fiona H. Marshall
President, Novartis
Fiona Marshall
President, Biomedical Research · Novartis
Cailin McGurk
Managing Director, Morgan Stanley
Phil McGurk
SVP, Takeda
Lisa Melton
Senior News Editor · Nature Biotechnology
46
Speaker index · continued
M—P
Giulia Menichetti
Assistant Professor in Medicine · Harvard Medical School
Fiona Miller
Managing Partner · quadraScope Capital
Sarah Mitchell
Editor in Chief · npj Aging
Mahdi Moqri
Harvard
Claris Munksgaard
Director, EMD Serono/Merck
Yves Fomekong Nanfack
Head of AI/ML Research, Takeda
Jim O'Neill
Speaker details to be confirmed
Matthew O’Connor
CEO, Cyclarity Therapeutics
Alice Park
Senior Health Correspondent · TIME
Amol Pawar
Executive Director, UBS
Hao Pei
Founder and CEO · MobiDrop
Justin Penzenstadler
Associate Director (Acting), OCHEN/OND/CDER · FDA
Anthony Philippakis
General Partner · GV
Alex Philippidis
Editor, Genetic Engineering and Biotechnology News
Jesse Poganik
Instructor · Harvard Medical School
47
Speaker index · continued
P—S
Dan Promislow
Senior Scientist and Scientific Advisor · HNRCA, Tufts University
Daniel Promislow
Senior Scientist, HNRCA, Tufts University
Marco Quarta
Co-Founder, Rubedo Life Sciences
Steven Quay
CEO, Atossa Therapeutics
Michael Ringel
COO, Life Biosciences
Nikolaj Kulahin Roed
Global Project Leader · Novo Nordisk
Nikolaj Roed
Global Project Leader, Novo Nordisk
Raiany Romanni-Klein
PhD · Harvard
Morten Scheibye-Knudsen
Professor, University of Copenhagen
Alexander Schuchmacher
THI Business School · THI; CPI · University of St. Gallen · Germany · Switzerland
Kirsten Seale
Scientist, TruDiagnostic
Naisha Shah
Senior Vice President of Data Science · BioAge
Andrew Shin
Chief Strategy Officer · Mass General Brigham
Jeffrey Siegel
Director, Drug Evaluation Sciences · FDA
David Sinclair
Professor, Harvard Medical School
48
Speaker index · continued
S—V
Nicole Sirotin
CEO, Institute for Healthier Living Abu Dhabi
Anna Skaya
General Partner, AniVC
Morten Sogaard
SVP, Astellas
Vishnu Sresht
Director, Genentech
Brianna Stubbs
Director of Translational Science · Buck Institute
Eric Sun
Assistant Professor · Massachusetts Institute of Technology
Björn Tackenberg
Head of Integrative Neuroscience, Roche
Erwin Tan
Senior Director · AARP
Patrick Temple-West
US Pharmaceutical Correspondent · Financial Times
Sebastian Thuault
Founding editor, Nature Aging
Max Unfried
Scientific Director · The Thalion Initiative
Derya Unutmaz
Professor · Jackson Laboratory for Genomic Medicine, Farmington, CT
Murali Venkatesan
Global Head of Danaher Ventures, Danaher
Alfredo Viegas
Managing Director, Oaktree Capital Management
Monika Vnuk
SVP, Sanofi
49
Speaker index · continued
V—Z
Alexandru-Ioan Voda
CEO · The Cat Health Company
Xingli Wang
Global Partner, Fosun Pharma
Christophe Weber
Ex-CEO, Takeda
Jonathan Weissman
Professor of Biology; Core Member, Whitehead Institute; HHMI Investigator · MIT · Whitehead Institute
Christoph Westphal
General Partner, Longwood Fund
Todd White
Managing Director · The Thalion Initiative
Kia Winslow
Sr. Director · BioAge
Tony Wyss-Coray
Professor, Stanford University
Eric Xing
President and University Professor · Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)
Vicky Yang
Associate Professor, Tufts University
Kejun Ying
Postdoctoral Scholar · Stanford University School of Medicine
Lowell M. Zeta
Acting Chief of Staff, Office of the Commissioner · FDA
Alex Zhavoronkov
CEO, Insilico Medicine
Tina Ziainia
Human Longevity
Garri Zmudze
Investor, LongeVC
50
Practical information
Live programmeAlways-current schedule
SpeakersProfiles and updates
RegistrationTickets and access
LocationDirections to the TreehouseVenue
David Rubenstein Treehouse
20 Western Avenue
Allston, Massachusetts
Canopy Hall · 3/F
Cedar Grove · 2/F
Allston, Massachusetts
Canopy Hall · 3/F
Cedar Grove · 2/F
Contact and safety
ardd@pharma.ai
agingpharma.org/codeofconduct
agingpharma.org/warning
The printed programme may change. Digital links always lead to the current official information.
51
ARDD 2026 network
Sponsors and partners
Tier 1
Tier 2 · No partners currently listed
Tier 3
52
Sponsors and partners · continued
Tier 3
ARTAN BIO
Tier 4
53
Sponsors and partners · continued
Tier 5
Supporting organizations
54
October 1–3, 2026
See you in Allston.
Keep the live programme with you for schedule updates, room changes and newly confirmed speakers.
agingpharma.org/program202655
October 1–3, 2026
Aging Research and Drug Discovery
agingpharma.org